(Q40531858)

English

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial

scientific article published on April 2004

Statements

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial (English)
Amadeu Pelegrí
José I Mayordomo
Jesús Florián
Santiago Vázquez
Marta Martn-Richard
Javier Virizuela
Antonio Antón
Spanish Group for Breast Cancer Research (GEICAM)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit